Landscapes / Targets

estrogen receptor

16 drugs act on estrogen receptor, in 75 active trials · Any stage · updated 18 Nov 2026

FollowEvery change as it happens, and a Monday email

Drugs16

DrugHow it worksCompanyStageNext dateDetails
Estrogen receptor antagonist
Approved Nov 2026soonPhase 2 trial completes
—
Rigel Pharmaceuticals +2 · Public PFE
Approved 30 Dec 2026Phase 3 trial completes
—
AstraZeneca · Public AZN
Approved 20 Apr 2027Phase 3 trial completes
Estrogen receptor antagonist
Eli Lilly · Public LLY
Approved Oct 2027Phase 3 trial completes
Estrogen receptor antagonist
AstraZeneca · Public AZN
Approved 1 Nov 2027Phase 3 trial completes
—
Phase 3 30 Nov 2026soonPhase 3 trial completes
—
Phase 3 Apr 2027Phase 3 trial completes
—
Roche · Public ROG.SW
Phase 3 31 Jul 2027Phase 2 trial completes
—
Phase 3 31 Aug 2028Phase 3 trial completes
—
Phase 3 Dec 2028Phase 3 trial completes
—
Phase 2 Nov 2026soonPhase 2 trial completes
—
Phase 2 31 Dec 2026Phase 2 trial completes
—
Phase 2 31 Oct 2027Phase 2 trial completes
—
Phase 1/2 —
—
Phase 1 Nov 2026soonPhase 1 trial completes
—
Phase 1 —

About this list

Checked
16 of 16 drugs. How we check
Matches
The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
Sources
ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Estrogen receptor

Following is part of Solo: you see every change to Estrogen receptor the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in